Bank of Montreal’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.6M Buy
+327,500
New +$26.2M 0.01% 831
2025
Q3
Sell
-85,000
Closed -$9.13M 3545
2025
Q2
$9.13M Sell
85,000
-15,000
-15% -$1.52M ﹤0.01% 1021
2025
Q1
$10.1M Buy
+100,000
New +$10.1M ﹤0.01% 923
2022
Q4
Sell
-6,700
Closed -$265 3989
2022
Q3
$265 Sell
6,700
-73,300
-92% -$2.94M ﹤0.01% 3016
2022
Q2
$3.04K Sell
80,000
-20,000
-20% -$814K ﹤0.01% 1685
2022
Q1
$4.47M Buy
+100,000
New +$4.33M ﹤0.01% 1549
2020
Q1
Sell
-49,600
Closed -$2.24M 4138
2019
Q4
$2.24M Buy
+49,600
New +$2.08M ﹤0.01% 1820

Other funds holding BSX

Bank of Montreal's BSX Position: Q1 2026 in Review

Bank of Montreal reduced its Boston Scientific (BSX) stake by 35% in Q1 2026, selling an estimated $57.3M and leaving 1,324,527 shares worth $83.1M. The position accounts for 0.03% of the portfolio, ranked #400.

Bank of Montreal first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $409M in Q3 2024. 1,671 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Bank of Montreal held 1,324,527 shares of Boston Scientific worth $83.1M as of Q1 2026.
  • Bank of Montreal sold 715,839 Boston Scientific shares in Q1 2026, an estimated $57.3M.
  • Boston Scientific made up 0.03% of Bank of Montreal's portfolio in Q1 2026, its #400 holding.
  • Bank of Montreal first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
  • Bank of Montreal's Boston Scientific position peaked at $409M in Q3 2024.
  • 1,671 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.